Therapeutic Class
WuXi’s ADC CDMO stages $500m IPO
Therapeutic ClassWuXi’s ADC CDMO stages $500m IPOWuXi’s ADC CDMO stages $500m IPO
WuXi XDC, a CDMO offering drug development and manufacturing for antibody drug conjugates (ADCs), is conducting a $500 million Hong Kong IPO.